financetom
Business
financetom
/
Business
/
Wells Fargo raises return targets after asset cap lifted; beats profit estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wells Fargo raises return targets after asset cap lifted; beats profit estimates
Oct 14, 2025 3:59 AM

(Reuters) -Wells Fargo ( WFC ) on Tuesday beat Wall Street estimates for third-quarter profit and raised its closely watched profitability target after regulators removed an asset cap imposed on the bank, paving the way for it to pursue growth.

The U.S. Federal Reserve lifted the lender's seven-year, $1.95 trillion asset cap in June, in a major landmark in its post-scandal recovery and freeing it to accelerate CEO Charlie Scharf's efforts to drive growth.

Shares of the San Francisco, California-based bank rose 3% in premarket trading.

The bank is now targeting a 17% to 18% return on tangible common equity (ROTCE), compared with its earlier target of 15%.

Wall Street had been anticipating Wells Fargo ( WFC ) to raise its the target following the removal of cap that had restricted its asset growth.

Net interest income - the difference between what the bank earns on loans and pays out on deposits - rose 2% to $11.95 billion in the September quarter from a year earlier.  

"While some economic uncertainty remains, the U.S. economy has been resilient and the financial health of our clients and customers remains strong," said Scharf said in a statement.

The Fed's September rate cut is expected to boost banks' interest income from the fourth quarter. 

U.S. banks have benefited from the Federal Reserve's rate cuts, which have eased deposit costs - the interest paid to customers for holding their savings. 

The fourth-largest U.S. lender's net income was $5.59 billion, or $1.66 per share, in the three months ended September 30, it said on Tuesday. That compares with $5.11 billion, or $1.42 per share, a year earlier.

Analysts had expected Wells Fargo ( WFC ) to post a profit of $1.55 per share, according to estimates compiled by LSEG.

(Reporting by Arasu Kannagi Basil in Bengaluru; editing by Lananh Nguyen and Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moderna Says US FDA Selects Rare Genetic Disorder Therapy for Pilot Program
Moderna Says US FDA Selects Rare Genetic Disorder Therapy for Pilot Program
Jun 6, 2024
08:13 AM EDT, 06/06/2024 (MT Newswires) -- Moderna ( MRNA ) said Thursday that the US Food and Drug Administration has selected its experimental therapy, mRNA-3705, to treat methylmalonic acidemia, a rare genetic disorder, for a pilot program aimed at supporting clinical trials to advance rare disease therapeutics. Selection for this program will enable enhanced communication with the US FDA,...
Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA
Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA
Jun 6, 2024
08:14 AM EDT, 06/06/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Thursday that data from the investigational combination of bulevirtide 10 milligram with pegylated interferon alfa-2a, or PegIFN, was superior to investigational bulevirtide 10 mg monotherapy for the treatment of compensated chronic hepatitis delta virus infection. The company is evaluating the efficacy and safety of bulevirtide as monotherapy...
BRIEF-Cycle Pharmaceuticals Announces All-Cash Proposal To Acquire Vanda Pharmaceuticals For $8.00 Per Share
BRIEF-Cycle Pharmaceuticals Announces All-Cash Proposal To Acquire Vanda Pharmaceuticals For $8.00 Per Share
Jun 6, 2024
June 6 (Reuters) - Vanda Pharmaceuticals Inc ( VNDA ): * CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE * CYCLE PHARMACEUTICALS LTD: PROPOSED DEAL REPRESENTING A TOTAL CASH CONSIDERATION OF $466 MILLION Source text for Eikon: Further company coverage: ...
Update: FAA Extends Cuts to Minimum Flight Requirements in New York Amid Traffic Controller Shortage
Update: FAA Extends Cuts to Minimum Flight Requirements in New York Amid Traffic Controller Shortage
Jun 6, 2024
08:12 AM EDT, 06/06/2024 (MT Newswires) -- (Updates with details from FAA's statement.) The Federal Aviation Administration said Wednesday it is further extending a waiver of minimum flight requirements at congested New York City-area airports through October 2025. The number of air traffic controllers is insufficient in New York for normal traffic levels, and increasing flexibility is needed to avoid...
Copyright 2023-2026 - www.financetom.com All Rights Reserved